New ADHD pill tested for Long-Term safety in kids
NCT ID NCT07087327
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests the safety of a daily medication called EB-1020 for children and teenagers with ADHD over 52 weeks. About 180 participants in Japan and China will take the drug once daily. The main goal is to see how many experience side effects during long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Hokkaido University Hospital
RECRUITINGSapporo, Japan
Conditions
Explore the condition pages connected to this study.